Sensus Healthcare, Inc.

Sensus Healthcare manufactures and distributes superficial radiation therapy devices used primarily for treating non-melanoma skin cancers and other dermatological conditions. The company's core product, the SRT-100 system, is a low-energy X-ray device that offers patients a non-surgical alternative to traditional treatment approaches. The SRT-100 Vision variant integrates ultrasound imaging, tumor volumetry, and treatment planning capabilities, while the SRT-100 Plus represents an enhanced version of the base system. Beyond radiation therapy equipment, the company sells complementary products including disposable safety items, shielding replacements, applicator tips, and a Transdermal Infusion system designed for needle-free drug delivery into dermal tissue.

The company also distributes laser devices for aesthetic and dermatological applications, including systems for hair removal, vascular lesion treatment, acne management, and pigmentation removal. Revenue streams derive from equipment sales, consumables and disposables, and service programs such as the Sentinel protection plan. Sensus markets its products primarily to private dermatology practices and radiation oncologists in both private and hospital-based settings across global markets.

Incorporated in Delaware in 2010, the company is headquartered in Boca Raton, Florida, and maintains a market capitalization of approximately $100 million.